Online Program

Return to main conference page

All Times EDT

Thursday, September 24
Thu, Sep 24, 1:30 PM - 2:45 PM
Virtual
Challenges and Recent Developments in Addressing Heterogeneity of Treatment Effects

Challenges and Recent Developments in Addressing Heterogeneity of Treatment Effects (301179)

Erik Bloomquist, FDA 
*Erik Bloomquist, FDA 

Keywords: Oncology

Following the talks, Dr. Erik Bloomquist from CDER/FDA will give a short discussion on each of the talks and also provide a regulatory perspective on how heterogeneous treatment effects are evaluated and considered.